Who decides if applications are appropriate and feasible?
This will be decided by the QUANTUM Tissue Access Committee (TAC). The committee includes members of the QUANTUM coordinating team (Biobank Manager, Governance Manager and Data Manager), the Chief Investigator (or suitable delegate), Clinical leads from each biobank module (as required) and a Consultant Pathologist.